Legend Biotech Corp ADR (NASDAQ:LEGN) Slides 1.61 Percent In Recent Trade, What Can We Expect Next?

Legend Biotech Corp ADR (NASDAQ:LEGN) traded at $59.88 at close of the session on Tuesday, July 23, made an upward move of 1.61% on its previous day’s price.

Looking at the stock we see that its previous close was $58.93 . In terms of its 52-week price range, LEGN has a high of $77.30 and a low of $38.60. The company’s stock has gained about 40.53% over that past 30 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Legend Biotech Corp ADR has a market cap of $10.91 billion.

Based on estimates by 10 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Legend Biotech Corp ADR (LEGN) stock as a Hold, while 10 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 21.15% off its SMA20 and 31.02% from its 50-day simple moving average. The RSI (14) is pointing at 78.39 while the volatility over the past week is 5.03% and jumps to 5.40% over the past one month. The beta value is 0.13, while the average true range (ATR) is currently pointing at 2.72. The average price target for the stock over the next 12 months is $82, with the estimates having a low of $60 and a high of $90. These price ends are -0.2% and -50.3% off the current price level respectively, although investors could be excited at the prospect of a -36.94% if the LEGN share price touches on the median price of $82.

Coming back to Legend Biotech Corp ADR (NASDAQ:LEGN), we note that the average 3-month trading volume was 1.23 million, while that of the preceding 10-day period stands at 1.72 million. Current shares outstanding are 181.91 million.

The insiders hold 0.83% of the company’s shares while institutions hold 47.17%. The data shows that short shares as of 2024-06-28, stood at 11.16 million at a short ratio of 8.58. This represents a 11.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.7711.77 short interest in shares outstanding on 2024-06-28. Shares short fall in June from the previous month at 13.26 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -0.48% down in year-to-date price movement.

Most Popular